Advanced molecular diagnostic kits designed to identify infectious agents and viral spreaders
Identifying the “SPREADER” COVID19 patients: early detection of active replicative SARS-Cov-2 viruses
ELYSIUM Cell Bio ITA has designed a method to distinguish those patients infected by SARS-CoV-2 virus together with BioMol laboratories develop a kit INFECT-004 to detect subgenomic-N and ORF 1a-b and E and RNAse P in naso-oropharyngeal swab in a highly specific and sensitive way. The NAT” (Nucleic Acid Testing) molecular method: is a qualitative determination of the viral genome of SARS-CoV-2 (in order to identify patient with “active” SARS-CoV-2 viruses). This CE-IVD KIT INFET-004-100 RDM Code: 2218988/R was patented by Founders of Elysium Cell bio ITA Spin-Off of University of Naples and CEINGE Biotecnologie Avanzate – Naples- Italy srl 80145.
Download below the brochure of the product:
https://www.biomollaboratories.it/wp-content/uploads/2024/01/INFET-004-INGLESE-VER-1.pdf
A patent related to this project: PCT/ EP2021/087512, “Method for determining Active SARS-Cov-2 infections” was filed.